Merck
CN
  • Differential thermodynamic driving force of first- and second-generation antihistamines to determine their binding affinity for human H1 receptors.

Differential thermodynamic driving force of first- and second-generation antihistamines to determine their binding affinity for human H1 receptors.

Biochemical pharmacology (2014-07-30)
Shigeru Hishinuma, Kenta Sugawara, Yoshihiro Uesawa, Hiroyuki Fukui, Masaru Shoji
摘要

Differential binding sites for first- and second-generation antihistamines were indicated on the basis of the crystal structure of human histamine H1 receptors. In this study, we evaluated differences between the thermodynamic driving forces of first- and second-generation antihistamines for human H1 receptors and their structural determinants. The binding enthalpy and entropy of 20 antihistamines were estimated with the van't Hoff equation using their dissociation constants obtained from their displacement curves against the binding of [(3)H]mepyramine to membrane preparations of Chinese hamster ovary cells expressing human H1 receptors at various temperatures from 4°C to 37°C. Structural determinants of antihistamines for their thermodynamic binding properties were assessed by quantitative structure-activity relationship (QSAR) analyses. We found that entropy-dependent binding was more evident in second- than first-generation antihistamines, resulting in enthalpy-entropy compensation between the binding forces of first- and second-generation antihistamines. QSAR analyses indicated that enthalpy-entropy compensation was determined by the sum of degrees, maximal electrostatic potentials, water-accessible surface area and hydrogen binding acceptor count of antihistamines to regulate their affinity for receptors. In conclusion, it was revealed that entropy-dependent hydrophobic interaction was more important in the binding of second-generation antihistamines, even though the hydrophilicity of second-generation antihistamines is generally increased. Furthermore, their structural determinants responsible for enthalpy-entropy compensation were explored by QSAR analyses. These findings may contribute to understanding the fundamental mechanisms of how the affinity of ligands for their receptors is regulated.

材料
货号
品牌
产品描述

Supelco
马来酸氯苯那敏, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
组胺 二盐酸盐, ≥99% (TLC), powder
Supelco
苯海拉明 盐酸盐, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
苯海拉明 盐酸盐, ≥98% (HPLC)
Sigma-Aldrich
组胺 二盐酸盐, ≥99.0% (AT)
Sigma-Aldrich
盐酸非索非那定 盐酸盐, >98% (HPLC)
Sigma-Aldrich
(±)-氯苯那敏 马来酸盐, ≥99% (perchloric acid titration)
Sigma-Aldrich
特非那定
Sigma-Aldrich
2-(2-吡啶基)乙胺, 95%
Sigma-Aldrich
异丙嗪 盐酸盐
Supelco
异丙嗪, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
奥洛他定 盐酸盐, ≥98% (HPLC)
USP
盐酸非索非那定 盐酸盐, United States Pharmacopeia (USP) Reference Standard
USP
马来酸氯苯那敏, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
地氯雷他定, powder, ≥98% (HPLC)
Supelco
吡拉明马来酸, Pharmaceutical Secondary Standard; Certified Reference Material
USP
苯海拉明 盐酸盐, United States Pharmacopeia (USP) Reference Standard
氯苯那敏, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
吡拉明 马来酸盐
Sigma-Aldrich
二盐酸倍他司汀 二盐酸盐, ≥98%
USP
奥洛他定 盐酸盐, United States Pharmacopeia (USP) Reference Standard
盐酸非索非那定 盐酸盐, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Oxatomide, ≥99%
地氯雷他定, European Pharmacopoeia (EP) Reference Standard
二盐酸倍他司汀 二盐酸盐, European Pharmacopoeia (EP) Reference Standard
USP
地氯雷他定, United States Pharmacopeia (USP) Reference Standard
组胺 二盐酸盐, European Pharmacopoeia (EP) Reference Standard
苯海拉明 盐酸盐, European Pharmacopoeia (EP) Reference Standard
苯甲嗪 盐酸盐, (European Pharmacopoeia (EP) Reference Standard)
USP
倍他司丁 盐酸盐, United States Pharmacopeia (USP) Reference Standard